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ABSTRACT 1 
Purpose: Patellar tendon abnormality (PTA) on diagnostic imaging is part of the diagnostic criteria for 2 
patellar tendinopathy. A PTA in addition to altered landing strategies are primary risk factors that 3 
increase the likelihood of asymptomatic athletes developing patellar tendinopathy.  Therefore, the aim 4 
of this study was to examine risk factors that are predictors of the presence and severity of a PTA in 5 
junior pre-elite athletes. 6 
Methods: Ten junior pre-elite male basketball athletes with a PTA were matched with ten athletes 7 
with normal patellar tendons.  Participants had patellar tendon morphology, Victorian Institute of Sport 8 
Assessment score (VISA), body composition, lower limb flexibility and maximum vertical jump height 9 
measured prior to performing five successful stop-jump tasks.  During each landing trial, both two- 10 
and three-dimensional kinematics and ground reaction forces were recorded.  Multiple regression 11 
analyses were used to identify factors for estimating PTA presence and severity, and discriminate 12 
analysis used to classify PTA presence. 13 
Results: Sixty-eight percent of variance for presence of a PTA was accounted for by hip joint range of 14 
motion (ROM), knee joint angle at initial foot-ground contact (IC) during stop-jump and quadriceps 15 
flexibility, whereas hip joint ROM and VISA accounted for 62% of variance for PTA severity.  16 
Prediction of the presence of a PTA was achieved with 95% accuracy and 95% cross-validation.  17 
Conclusions: An easily implemented, reliable and valid movement screening tool comprising of three 18 
criteria’s enables coaches and/or clinicians to predict for the presence and severity of a PTA in 19 
asymptomatic athletes.  This enables identification of asymptomatic athletes at higher risk of 20 
developing patellar tendinopathy, which allows the development of effective preventative measures to 21 
aid in the reduction of patellar tendinopathy injury prevalence. 22 
Keywords: Knee injury, biomechanics, movement screening, prevention through prediction, landing 23 
  24 
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INTRODUCTION 1 
Paragraph Number 1.  Identified in repetitive jumping sports, overuse injuries such as patellar 2 
tendinopathy have increased (23), with a prevalence range from 10% in college athletes (39) to 32% 3 
in elite basketball athletes (23).  Although the overall prevalence across different sports indicates that 4 
every fifth elite athlete will suffer patellar tendinopathy within their career, it is particularly concerning 5 
that in basketball 55% of elite basketball players have reported current or previous patellar 6 
tendinopathy symptoms (23).  Classified as a degenerating overuse knee injury (33), patellar 7 
tendinopathy is diagnosed using a combination of a history of activity related pain (25), tenderness on 8 
palpation (26), Victorian Institute of Sport Assessment (VISA) score of less than 80 (38), and patellar 9 
tendon abnormality (PTA) on diagnostic imaging (9).  As PTA’s tend to emerge during the 10 
developmental adolescent years (9), it is imperative that risk factors associated with patellar 11 
tendinopathy within the pre-elite population be identified and understood in order to develop effective 12 
preventative measures to aid in the reduction of patellar tendinopathy injury rates (36). Prevention 13 
through prediction aims to reduce injury rates by predicting athletes at risk of developing patellar 14 
tendinopathy within the sporting population and implementing risk modification strategies to reduce 15 
the patellar tendinopathy incidence rate. 16 
Paragraph Number 2.  With controversy surrounding the precise etiology of PT, a combination of 17 
internal and external risk factors is thought to play a part in the development of patellar tendinopathy 18 
(10, 33).  Although the presence of a PTA is used to confirm diagnosis of patellar tendinopathy (9, 19 
26), PTA’s have also been identified as a risk factor in the development of patellar tendinopathy (8).  20 
Asymptomatic athletes with a PTA have an increased likelihood of developing patellar tendinopathy 21 
(7, 8), especially males who are twice as likely to develop a PTA compared to females (9).  22 
Regardless of this supporting evidence of PTA as a risk factor for patellar tendinopathy development, 23 
the clinical importance of PTA changes have not yet been identified as the size of the PTA varies over 24 
time and is unable to predict patellar tendinopathy symptoms (18).  Nevertheless, identification of 25 
asymptomatic athletes with a PTA utilising a different landing strategy may provide a method to 26 
identify these athletes at risk of developing patellar tendinopathy. 27 
Paragraph Number 3.  With repetitive landing being identified as the primary risk factor of patellar 28 
tendinopathy (10, 33), symptomatic athletes with patellar tendinopathy (4, 34) and asymptomatic 29 
athletes with a PTA (13) have been associated with altered landing strategies.  The critical 30 
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characteristics associated with these altered landing strategies are knee and hip joint motion.  During 1 
a dynamic landing, maximum knee joint flexion is the strongest predictor of symptomatic patellar 2 
tendinopathy (34), and asymptomatic athletes with PTA compared to athletes with normal patellar 3 
tendons displayed increased knee joint flexion at initial foot-ground contact (IC) and different hip 4 
movement strategies, whereby they extend their hip during landing as opposed to flexing their hips 5 
(13). 6 
Paragraph Number 4.  As these altered landing strategies primarily occur in the sagittal plane, it may 7 
be possible to identify athletes with these altered landing patterns utilizing a simple two-dimensional 8 
video camera as opposed to three-dimensional motion analysis.  Although three-dimensional lower 9 
limb motion analysis is considered the gold standard of assessing landing technique, it is costly, and 10 
extensively time and space consuming (29).  It is therefore not practical for all coaches and/or 11 
clinicians to utilize this method.  A successful alternative method for validly screening athletes at risk 12 
in a cost, time and space effective method is to screen athletes using a two-dimensional video 13 
analysis, previously used in knee joint injuries (31).  Nevertheless, the two-dimensional video analysis 14 
may be limited if there is a lack of validity between three- and two-dimensional measures (29).  15 
Therefore, further research is warranted to determine if this analysis method could be implemented to 16 
developing a movement screening tool for another knee joint injury, patellar tendinopathy. 17 
Paragraph Number 5.  Other risk factors associated with patellar tendinopathy that are also readily 18 
measurable and modifiable that may be included with a movement screening tool to assess injury risk 19 
include increased adiposity (10, 17), decreased lower limb flexibility (26, 39), and higher vertical jump 20 
height (25).  If any of these modifiable risk factors are meaningful predictors of an increased risk of 21 
developing a PTA and therefore patellar tendinopathy, these risk factors should be used to screen 22 
athletes.  Athletes identified as being at risk can then have modification strategies implemented to 23 
reduce injury risk and/or prevalence of patellar tendinopathy. 24 
Paragraph Number 6.  The present study aimed to i) determine the risk factors that are most 25 
influential in predicting the incidence and severity of PTA and ii) to develop an easily implemented, 26 
valid and reliable movement screening tool based on critical risk factors associated with patellar 27 
tendinopathy that can be utilized by coaches and/or clinicians to identify their athletes who are at 28 
higher risk of developing patellar tendinopathy.  We hypothesised that a criteria of altered hip and 29 
knee motion strategies during a stop-jump task, lower limb flexibility, increased adiposity, and 30 
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increased vertical jump performance will allow a prevention through prediction approach to determine 1 
the i) presence; and ii) severity of a PTA in asymptomatic individuals. 2 
METHODS 3 
Participants 4 
Paragraph Number 7.  Twenty-two junior pre-elite male basketball athletes (mean age = 17.7 ± 1.5 5 
years, height = 183 ± 10 cm; mass = 78.0 ± 14.7 kg) were recruited from junior pre-elite rural 6 
representative teams.  The presence of a PTA (Table 1) (7) was assessed by an experienced 7 
musculoskeletal sonographer (M.J., PRP Imaging Bathurst NSW Australia) using a 12MHz linear 8 
array ultrasound transducer (Toshiba, Aplio XG, Japan).  Body composition was estimated by a dual-9 
energy X-ray absorptiometry (DEXA; XR800, Norland, Cooper Surgical Company, USA) using a 10 
supine whole body scan performed by a qualified technician (scanning resolution = 6.5 x 13.0 mm; 11 
scanning speed = 130 mm s-1).  Each participant’s height, body composition, anthropometric 12 
dimensions, static dorsiflexion (26), static hamstring (39) and quadriceps flexibility (14), and maximum 13 
vertical jump height (25, 36) were measured before determining their dominant lower limb on the 14 
basis of their preferred kicking leg (15).  Ten participants with PTA with no current signs of patellar 15 
tendinopathy were individually matched for height, mass, and test limb to ten participants with normal 16 
patellar tendons (13).  The lower limb with the larger PTA area (mm2) (24) was selected for analysis if 17 
a participant had bilateral PTA.  Written informed consent was obtained from each participant prior to 18 
data collection, with parental/guardian consent obtained for minors. All methods were approved by the 19 
institution’s Human Research Ethics Committee (2011/071). 20 
< Insert Table 1 about here > 21 
Experimental Task 22 
Paragraph Number 8.  Since a substantial component of basketball play is rapid acceleration, 23 
deceleration (28), and repetitive landing (27), the stop-jump task was chosen as the experimental 24 
task.  The stop-jump task involved five phases, which included a horizontal preparation, horizontal 25 
landing, horizontal take-off, vertical preparation and vertical landing phase (12).  Each participant was 26 
required to perform the horizontal preparation phase accelerating forwards for 10 m towards a force 27 
platform (mean approach speed = 5.1 ± 0.3 m⋅s-1), which was measured using infrared timing lights 28 
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(Speed Light, Swift Sports Equipment, Lismore, Australia).  Then each participant performed the 1 
horizontal landing phase by jumping off one lower limb then stopping abruptly using a simultaneous 2 
two-foot landing with one foot wholly contacting a force platform, and then immediately jump vertically 3 
upwards (horizontal takeoff phase) off the ground to strike a ball suspended from the ceiling (vertical 4 
preparation phase), with both hands (vertical jump height = 52 ± 7 cm).  Finally, participants 5 
performed the vertical landing phase by landing on both feet a second time (vertical landing phase).  6 
Participants performed five successful stop-jump movements for each lower limb.  A successful stop-7 
jump was defined as a participant obtaining an adequate approach speed of between 4.5 and 5.5  8 
m⋅s-1 during the horizontal preparation phase, placing a foot wholly on the force platform during the 9 
horizontal landing phase, and contacting ball suspended from the ceiling with both hands.  The 10 
approach speed was based on the 10 m sprint time (3) and average sprint duration of 2.1 s (1) as 11 
these are typical values in junior elite male basketball.  During task familiarisation, jump height effort 12 
was standardised among the participants by positioning the ball at the maximum height each 13 
participant could touch the ball with both hands after performing the horizontal landing phase of the 14 
stop-jump task. 15 
Experimental Procedure 16 
Paragraph Number 9.  Prior to completing a 5- to 10-min warm-up on a cycle ergometer (Monark 17 
828E, Varburg, Sweden), a static trial was performed.  Each participant was then familiarised with the 18 
stop-jump task before performing at least five successful stop-jump trials.  During each trial, the 19 
ground reaction forces generated at landing were recorded (2400 Hz) using a multichannel force 20 
platform with built-in charge amplifier (Type 9281CA, Kistler, Winterthur, Switzerland) embedded in 21 
the floor and connected to a control unit (Type 5233A, Kistler, Winterthur, Switzerland).  The 22 
participant’s three-dimensional lower limb and trunk motion was recorded (240 Hz) using a Qualisys 23 
Oqus 300 camera system (Qualisys AB, Göteborg, Sweden) and two-dimensional lower limb and 24 
trunk motion was recorded (30 Hz) using a digital video camera (GZ-MG465, JVC, Yokohama, 25 
Japan).  Passive reflective markers were placed on each participant’s lower limbs, pelvis and torso, 26 
on the shoe at the first and fifth metatarsal head, mid anterior foot and calcaneous, lateral and medial 27 
malleolus, lateral and medial femoral epicondyle, four-marker cluster placed on the leg and thigh, 28 
greater trochanter, anterior superior iliac spine, posterior superior iliac spine, iliac crest, sternal notch, 29 
xiphoid process, acromion, lumbo-sacral (L5-S1) intervertebral joint space, thoraco-lumbar (T12-L1) 30 
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intervertebral joint space, bilaterally on the ribcage at the level of the T12-L1 intervertebral joint space 1 
and immediately superior to the iliac crest marker, and five tracking markers placed on the lumbar 2 
region.  To avoid losing view of the passive reflective markers, the participant’s wore minimal clothing 3 
(shorts), and their own socks and athletic running shoes. 4 
Data Reduction and Analysis 5 
Paragraph Number 10.  Analysis of the three-dimensional kinematic and kinetic data was performed 6 
using Visual 3D software (Version 4, C-Motion, Germantown, MD).  The raw kinematic coordinates, 7 
ground reaction forces, free moments and centre of pressure data were initially filtered using a fourth-8 
order zero-phase-shift Butterworth digital low pass filter (fc = 18 Hz) before calculating individual 9 
ground reaction forces and joint kinematics.  Segment masses were defined from Zatsiorsky et al.  10 
(40) for the foot, shank and thigh segments, and Pearsall et al. (32) for the pelvis, lumbar, thorax and 11 
trunk segments.  Segmental inertial properties of each segment were modelled using geometric 12 
primitives (20), with the foot, shank and thigh defined as a frusta of a right cone (16), and the pelvis, 13 
lumbar, thorax and trunk defined as elliptical cylinders (35).  With respect to the Cardanic axes of the 14 
local joint coordinate system, intersegmental joint angles were expressed for knee and hip joint 15 
angles as flexion-extension, adduction-abduction and internal-external rotation, and trunk angles as 16 
extension-flexion, right-left lateral flexion, and left-right rotation.  Using the 18 Hz filtered kinetic data, 17 
the landing phase was defined from IC when the vertical ground reaction force exceeded 10 N to the 18 
first local minimum, to peak knee joint flexion angle (Kneemax).  For each trial, the maximum vertical 19 
jump height (11), knee and hip joints and trunk segment kinematics at IC and at the time of the 20 
KneeMax were calculated.   21 
Paragraph Number 11.  The two-dimensional video data of the lower limb and trunk motion was 22 
analysed using Silicon Coach Pro (Version 6; Silicon Coach Ltd., Dunedin, New Zealand) software.  23 
Based on the passive reflective markers, knee and hip joint, and trunk segment angles were 24 
calculated in the sagittal plane at IC and at the time of the KneeMax.  The DEXA scan was analysed 25 
(IlluminatusDXA, ver.  4.2.0, USA), and total body fat mass (TB-FM) (22) quantities were calculated. 26 
Statistical Analysis 27 
Paragraph Number 12.  Multiple regression analysis (forward method) was used to determine 28 
substantial factors in estimating PTA (i) presence and (ii) severity (area of the PTA within the patellar 29 
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tendon (24); dependent variables).  All independent variables were continuous and included seven 1 
different three-dimensional variables during the landing phase (knee and hip joint angle, and trunk 2 
segment angle at IC and at the time of the KneeMax, and hip joint angle range of motion (hip joint 3 
angle at Kneemax minus hip joint angle at IC)) and five other variables (dorsiflexion, hamstring and 4 
quadriceps flexibility, maximum vertical jump height, and adiposity).  Independent variables identified 5 
as substantial predictors of PTA presence (0 = no evidence of PTA, 1 = evidence of any degree of 6 
PTA) from the respective regression analysis were included in a discriminate analysis to correctly 7 
classify PTA presence using a leave-one-out classification.  The validity of two-dimensional data 8 
collection was determined using a linear regression equation to calculate the magnitude of the 9 
standard error of the estimate (SEE) between two- (independent variable) and three-dimensional 10 
(dependent variable) kinematic data.  All regressions and discriminate analyses were performed using 11 
PASW statistical package (Version 17.0.1, SPSS Inc, Chicago, IL).  Intra-rater reliability of the lower 12 
limb and trunk segment two-dimensional kinematic data analysis was assessed for six participants on 13 
three separate occasions using consecutive trial pairs of the two-dimensional kinematic data (Analysis 14 
Session 1 and 2; Analysis Session 2 and 3) using the typical error of measurement (TEM; calculated 15 
as a coefficient of variation), percent change in the mean, and intra-class correlation using Microsoft 16 
Excel (21). 17 
RESULTS 18 
Paragraph Number 13.  Means (±SD) of the variables used within the multiple regression analyses to 19 
predict PTA (i) presence and (ii) severity are illustrated in Table 2.  The multiple regression model 20 
indicated that the substantial predictors of (i) presence (Equation 1) were hip joint ROM (R2=0.474), 21 
knee flexion at IC (R2=0.112) and quadriceps flexibility (R2=0.090) and, (ii) severity (Equation 2) of 22 
PTA were VISA (R2=0.392) and hip ROM (R2=0.124), with the standard error of each equation 0.30 23 
and 12.33 respectively.  Discriminate analysis indicated that the respective predictors were able to 24 
classify the presence of PTA with 95% accuracy and 95% cross-validation. 25 
< Insert Table 2 about here > 26 
Equation 1: Presence of PTA 27 
𝑦′ = −0.965 + (0.024 × ℎ𝑖𝑝 𝑅𝑂𝑀) + (0.013 × 𝑞𝑢𝑎𝑑𝑟𝑖𝑐𝑒𝑝𝑠 𝑓𝑙𝑒𝑥𝑖𝑏𝑖𝑙𝑖𝑡𝑦) + (0.024 × 𝑘𝑛𝑒𝑒 𝑓𝑙𝑒𝑥𝑖𝑜𝑛 𝑎𝑡 𝐼𝐶) 
Note: a result that exceeds 1 indicates the predicted presence of PTA.  A result of >1 indicates no 28 
predicted presence of PTA. 29 
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Equation 2: Severity of PTA 1 
𝑦′ = 120.742 + (−1.139 × 𝑉𝐼𝑆𝐴) + (0.979 × ℎ𝑖𝑝 𝑅𝑂𝑀) 
Note: a result indicates the area, in mm2, of PTA. 2 
Paragraph Number 14.  The two-dimensional kinematic variables showed excellent reliability 3 
between Analysis Session 2 and 3 and Analysis Sessions 1 and 2, regarding percent change in the 4 
mean, TEM and test-retest correlation (Table 3).  The equation of the two-dimensional kinematic data 5 
to predict three-dimensional kinematic data is shown in Table 4.   6 
< Insert Table 3 and 4 about here > 7 
DISCUSSION 8 
Paragraph Number 15.  Injuries in sport can substantially affect an athlete’s career, which is why 9 
many sporting teams have recently adopted a prevention through prediction approach that involves 10 
movement screening tools (30).  In planning and implementing movement screening assessment 11 
tools, it is critical that the influence of injury specific risk factors be identified to enable appropriate 12 
modification strategies to be developed and implemented to reduce the risk of patellar tendinopathy.  13 
The results of this present study identify substantial variables that enable the prediction of PTA 14 
presence and severity in pre-elite basketball athletes, which will allow risk factor modification 15 
strategies to be implemented, and therefore enable a prevention through prediction approach to 16 
reduce the risk of patellar tendinopathy in athletes. 17 
Paragraph Number 16.  In identifying variables to predict PTA in asymptomatic athletes, the 18 
importance of lumbopelvic control within rehabilitation programs for patellar tendinopathy was 19 
confirmed within this present study as the primary risk factor that predicted both the presence and 20 
severity of a PTA was hip joint ROM.  That is, asymptomatic athletes with a PTA compared to athletes 21 
with normal patellar tendons utilized a different hip movement strategy, whereby they displayed a 22 
negative hip joint ROM, indicating that they extended their hip joint while landing as opposed to 23 
flexing, which was consistent with our previously findings (13).  Furthermore, the larger magnitude of 24 
this negative hip joint ROM predicted an increase PTA area in participants with a PTA.  By utilising 25 
this different hip movement strategy, the PTA athletes require greater forward translation of the center 26 
of mass in relation to the base of support as the center of mass is at a greater posterior location at IC, 27 
which in turn, may increase the tensile and compressive loads on the proximal part of the patellar 28 
tendon and contribute to the development of a PTA (13). 29 
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Paragraph Number 17.  Asymptomatic athletes with a PTA also landed with greater knee flexion at 1 
IC compared to athletes with normal patellar tendons, which may further contribute to greater tensile 2 
loading of the superficial fibers of the patellar tendon on the anterior surface and contribute to higher 3 
compression of the patellar tendon (2), and also via a greater ratio of the quadriceps tendon force-to-4 
patellar tendon force (5).  As histological adaptations occur as a result of increased patellar tendon 5 
tension and compressive loads (19), this present study provides further evidence that the direction of 6 
the load that the patellar tendon sustains is more critical than the magnitude of this load in the 7 
development of a PTA (13), and the role compressive loads play within patellar tendinopathy 8 
development. 9 
Paragraph Number 18.  Reduced quadriceps flexibility was the only other substantial predictor of the 10 
presence of a PTA in asymptomatic athletes.  This supports previous research that has associated 11 
this variable as a risk factor in the development of patellar tendinopathy (6, 39).  Although the 12 
relationship between patellar tendinopathy and flexibility is not conclusive, it has been suggested that 13 
reduce flexibility may lead to greater load exerted on the tendon (39).  However, asymptomatic 14 
athletes with a PTA have been shown to dissipate similar patellar tendon loads during landing stop-15 
jump compared to athletes with normal patellar tendons (13), suggesting that quadriceps flexibility 16 
may not affect the magnitude of the load sustained by the patellar tendon during landing.  Such a 17 
finding further suggests that quadriceps flexibility may influence the direction of this load, which is 18 
more critical in the development of patellar tendinopathy. 19 
Paragraph Number 19.  Identification of hip joint ROM, quadriceps flexibility and knee joint angle at 20 
IC as meaningful predictors of the presence of a PTA, allows these variables to be used as the 21 
movement screening criteria to predict asymptomatic athletes at risk of developing a PTA.  If an 22 
athlete is identified at higher risk of developing PTA (i.e. a result score of >1.0 in Equation 2) risk 23 
modification strategies such as landing retraining can be implemented to potentially reduce further 24 
progression of the asymptomatic PTA into patellar tendinopathy.  With an SEE of 0.30 in Equation 2, 25 
a score as low as 0.7 indicates that referral for further biomechanical screening with diagnostic 26 
imaging is warranted.  This movement screening criteria is therefore a functional and valid tool that 27 
can be easily implemented at a community sporting level to allow coaches and/or clinicians to screen 28 
their asymptomatic athletes to predict PTA presence, and thereby allowing risk factor modification 29 
strategies to be employed by these athletes at increased risk of developing patellar tendinopathy. 30 
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Paragraph Number 20.  In relation to severity of the PTA within asymptomatic athletes, the VISA 1 
score was the second strongest predictor after hip joint ROM.  As VISA score is used to aid in the 2 
diagnosis of patellar tendinopathy, with a score less than 80 indicating patellar tendinopathy (38), the 3 
lower VISA predicts a larger PTA area within asymptomatic athletes.  While the VISA is a highly 4 
reliable test (37), and is sensitive to changes in severity allowing it to be used to monitor rehabilitation 5 
progress of athletes recovering from patellar tendinopathy (37), the clinical importance of area of a 6 
PTA and VISA in athletes with patellar tendinopathy remains unclear. 7 
Paragraph Number 21.  Although the predictors of the presence and severity of a PTA during landing 8 
were assessed with the criterion of three-dimensional analysis, using a two-dimensional video 9 
analysis to screen athletes at risk would not be valid if there was a lack of consistency between three- 10 
and two-dimensional (29).  Nevertheless, within this current study there is consistent relationship 11 
between three- and two-dimensional data indicated by the low SEE, which shows that two-12 
dimensional data may be used to estimate three-dimensional data with a low amount of error 13 
(between 1.6 – 5.3°, Table 4).  Furthermore, the intra-tester reliability of performing the two-14 
dimensional analysis indicates that there is an excellent reliability for the lower limb and trunk 15 
segments (TEM ~1-2%, Table 3).  Therefore, based on the results of this study, it is suggested that 16 
two-dimensional motion analysis is a reliable and valid alternative for coaches and clinicians relative 17 
to the costly criterion three-dimensional motion analysis to predict three-dimensional data values. 18 
Paragraph Number 22.  The authors acknowledge potential limitations within this study.  Firstly, the 19 
etiology of diverse types of patellar tendinopathy are suggested to be different (10, 17), and as the 20 
asymptomatic participants with PTA incorporated in this study included both bi- and uni-lateral PTA 21 
athletes.  This is suggested to potentially have an influence on the results, although further research 22 
is required.  Further limitations of this study include the age and skill level of the target population 23 
included for participation.  As participants were limited to junior pre-elite athletes, it is unknown if the 24 
results observed in this study could be replicated in other age groups and/or competition levels such 25 
as elite athletes.  Therefore, we recommended that future research investigate an additional 26 
independent sample of athletes to confirm this current study’s findings, and based on the three 27 
criterion, development of effective preventative measures are developed to aid in the reduction of 28 
patellar tendinopathy injury. 29 
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CONCLUSIONS 1 
Paragraph Number 23.  With hip joint ROM and knee joint angle at IC during stop-jump landing, and 2 
quadriceps flexibility as significant predictors of the presence of a PTA, and are easily measured and 3 
identified, a simple and reliable movement screening tool incorporating only these risk factors during 4 
the landing phase of a stop-jump has been developed to allow coaches and/or clinicians to screen 5 
and determine the presence and severity of a PTA, and thereby enabling risk factor modification 6 
strategies to be developed and implemented, reducing the risk of developing patellar tendinopathy. 7 
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